GO:0016010 dystrophin-associated glycoprotein complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016010 defines the dystrophin-associated glycoprotein complex (DGC), a multiprotein complex that mechanically links the cytoskeleton to the extracellular matrix.
• The DGC comprises transmembrane, cytoplasmic, and extracellular proteins including dystrophin, sarcoglycans, dystroglycan, dystrobrevins, syntrophins, sarcospan, caveolin-3, and NO synthase.
• DGC dysfunction is central to muscular dystrophies, cardiomyopathies, and synaptic pathologies.
• The DGC interacts functionally with ion channels, extracellular matrix components, and the ubiquitin-proteasome system.
• Mass spectrometry and biochemical approaches have refined the DGC interactome, revealing context-dependent composition.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) are essential for dissecting DGC gene function in muscle and neurons.
Description
The dystrophin-associated glycoprotein complex (DGC), annotated as GO:0016010, is a multiprotein complex that forms a strong mechanical link between the cytoskeleton and the extracellular matrix. It is typical of, but not confined to, muscle cells, and is composed of transmembrane, cytoplasmic, and extracellular proteins including dystrophin, sarcoglycans, dystroglycan, dystrobrevins, syntrophins, sarcospan, caveolin-3, and NO synthase. The DGC is essential for sarcolemmal stability and signaling in skeletal and cardiac muscle, and it also plays critical roles at synapses in the nervous system. Researchers study GO:0016010 because mutations in DGC components cause severe muscular dystrophies and cardiomyopathies, and because the complex integrates mechanical and signaling functions that are relevant to cell biology, neuroscience, and disease modeling. Understanding DGC composition, assembly, and regulation is therefore fundamental for developing targeted therapies and for interpreting genetic variants in muscle and nerve disorders.
dystrophin-associated glycoprotein complex At A Glance
| GO ID | GO:0016010 |
|---|---|
| GO term | dystrophin-associated glycoprotein complex |
| Ontology | cellular_component |
| Synonym | DGC; dystrophin glycoprotein complex |
| Major function | Mechanical link between cytoskeleton and extracellular matrix; signaling scaffold |
| Key components | Dystrophin, sarcoglycans, dystroglycan, dystrobrevins, syntrophins, sarcospan, caveolin-3, NO synthase |
| Tissue distribution | Muscle (skeletal, cardiac) and nervous system |
| Associated diseases | Muscular dystrophies, cardiomyopathies, synaptic disorders |
What Is GO:0016010?
GO:0016010 describes a multiprotein complex that physically connects the cytoskeleton to the extracellular matrix, providing mechanical stability and signaling capacity. The complex includes dystrophin, sarcoglycans, dystroglycan, dystrobrevins, syntrophins, sarcospan, caveolin-3, and NO synthase, and it is found in muscle and non-muscle cells.
Why Is dystrophin-associated glycoprotein complex Important in Cell Biology?
The DGC is a central node for mechanotransduction and signaling in muscle and nerve. Its disruption leads to sarcolemmal fragility, impaired ion channel regulation, and altered extracellular matrix interactions, which underlie muscular dystrophies and cardiomyopathies. Moreover, DGC components at synapses influence neurotransmission and are implicated in neuropsychiatric and neurodegenerative conditions. Studying GO:0016010 therefore bridges cell biology, physiology, and disease mechanisms, and it provides a framework for therapeutic targeting.
• Mutations in DGC genes cause Duchenne and Becker muscular dystrophies and limb-girdle muscular dystrophies.
• The DGC is critical for cardiac function, and its dysfunction contributes to dilated cardiomyopathy and arrhythmias.
• At synapses, DGC proteins regulate receptor clustering and signaling, linking to neurological disorders.
• The DGC interacts with ion channels, modulating excitability and calcium homeostasis.
• Extracellular matrix-dystroglycan interactions influence tissue dynamics and repair.
• Ubiquitin-proteasome system and autophagy misregulation exacerbate DGC-related dystrophies.
• Mass spectrometry-based interactomics reveals context-specific DGC composition.
• DGC components are potential biomarkers and therapeutic targets in muscle and heart disease.
• CRISPR screens can identify modifiers of DGC function and stability.
• The DGC serves as a model for studying mechanotransduction and membrane organization.
What Happens During dystrophin-associated glycoprotein complex?
Assembly and Membrane Targeting
In simple terms: The DGC is built step by step at the cell membrane, linking inside and outside the cell.
Assembly of the DGC begins with dystroglycan, which is cleaved into alpha and beta subunits; alpha-dystroglycan binds extracellular matrix proteins such as laminin, while beta-dystroglycan anchors to the membrane and binds dystrophin. Dystrophin then connects to the actin cytoskeleton, and sarcoglycans, sarcospan, syntrophins, dystrobrevins, caveolin-3, and NO synthase are recruited to form the mature complex. This assembly is critical for sarcolemmal integrity and signaling.
Mechanical Stabilization
In simple terms: The DGC acts like a shock absorber, protecting muscle cells from damage during contraction.
By linking the actin cytoskeleton to the extracellular matrix, the DGC distributes mechanical stress and prevents sarcolemmal rupture during muscle contraction. Loss of dystrophin or other DGC components leads to membrane fragility and progressive muscle degeneration, as seen in muscular dystrophies.
Signaling and Ion Channel Regulation
In simple terms: The DGC also sends signals and controls ion channels in the membrane.
The DGC serves as a scaffold for signaling molecules, including neuronal nitric oxide synthase (nNOS), and modulates ion channels such as voltage-gated sodium and calcium channels. This regulation influences excitability, calcium handling, and gene expression, and its disruption contributes to cardiac and skeletal muscle pathologies.
Synaptic Functions
In simple terms: In the brain, the DGC helps organize synapses and receptor clustering.
In the nervous system, DGC components are present at synapses and regulate the clustering of neurotransmitter receptors and synaptic signaling. Dystrophin and dystroglycan isoforms in the brain influence synaptic plasticity and are implicated in cognitive and neuropsychiatric disorders.
Key Genes Involved in GO:0016010 dystrophin-associated glycoprotein complex
The following genes encode core components and interactors of the dystrophin-associated glycoprotein complex (GO:0016010).
| Gene | Major Role | Research Relevance |
|---|---|---|
| DMD | Dystrophin; links actin cytoskeleton to DGC | Mutations cause Duchenne/Becker muscular dystrophy |
| DAG1 | Dystroglycan; binds extracellular matrix and dystrophin | Central to DGC assembly and muscular dystrophies |
| SGCA | Alpha-sarcoglycan; transmembrane component | Limb-girdle muscular dystrophy type 2D |
| SGCB | Beta-sarcoglycan; stabilizes sarcoglycan complex | Limb-girdle muscular dystrophy type 2E |
| SGCG | Gamma-sarcoglycan; sarcoglycan complex | Limb-girdle muscular dystrophy type 2C |
| SGCD | Delta-sarcoglycan; sarcoglycan complex | Cardiomyopathy and muscular dystrophy |
| SNTB1 | Beta-1-syntrophin; scaffold for signaling proteins | Regulates nNOS and ion channels |
| SNTA1 | Alpha-1-syntrophin; adaptor protein | Modulates synaptic and muscle signaling |
| DTNA | Alpha-dystrobrevin; cytoplasmic DGC component | Links DGC to signaling and cytoskeleton |
| DTNB | Beta-dystrobrevin; cytoplasmic DGC component | Muscle and brain functions |
| SSPN | Sarcospan; transmembrane component | Stabilizes DGC and modulates muscle pathology |
| CAV3 | Caveolin-3; membrane scaffolding | Mutations cause caveolinopathies and muscular dystrophy |
| NOS1 | Neuronal nitric oxide synthase; signaling | Regulates blood flow and muscle metabolism |
| UTRN | Utrophin; fetal homolog of dystrophin | Therapeutic target for DMD |
| LAMA2 | Laminin alpha-2; extracellular matrix ligand | Congenital muscular dystrophy |
| FKRP | Glycosyltransferase for alpha-dystroglycan | Dystroglycanopathies |
| POMT1 | O-mannosyltransferase for alpha-dystroglycan | Walker-Warburg syndrome |
| POMGNT1 | Glycosyltransferase for alpha-dystroglycan | Muscle-eye-brain disease |
How Is dystrophin-associated glycoprotein complex Regulated?
The DGC is regulated at multiple levels, including gene expression, post-translational modifications, and protein degradation. The ubiquitin-proteasome system and autophagy influence the stability of DGC components, and their misregulation contributes to muscular dystrophies. Glycosylation of alpha-dystroglycan is essential for its ligand-binding activity, and defects in glycosyltransferases cause dystroglycanopathies. Additionally, the DGC interacts with ion channels and signaling molecules, and its composition can vary by tissue and developmental stage.
dystrophin-associated glycoprotein complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMD | Duchenne muscular dystrophy | DMD knockout mouse; CRISPR KO in myoblasts |
| SGCA | Limb-girdle muscular dystrophy 2D | SGCA knockout mouse; patient iPSC-derived myotubes |
| SGCD | Cardiomyopathy | Cardiac-specific SGCD KO mouse |
| DAG1 | Dystroglycanopathy | DAG1 conditional KO; glycosylation mutant knock-in |
| NOS1 | Muscle ischemia and metabolism | NOS1 knockout mouse; CRISPR point mutation |
Muscular Dystrophies
Mutations in DGC genes, including DMD, sarcoglycans, and DAG1, cause a spectrum of muscular dystrophies characterized by progressive muscle weakness and degeneration. Loss of dystrophin leads to Duchenne muscular dystrophy, while sarcoglycan mutations cause limb-girdle muscular dystrophies. The DGC is also a target for therapeutic strategies such as utrophin upregulation and gene editing.
Cardiomyopathies
The DGC is essential for cardiac muscle integrity, and its dysfunction is linked to dilated cardiomyopathy, arrhythmias, and heart failure. Mutations in DMD, SGCD, and other DGC genes can cause cardiac-specific phenotypes, and DGC-related cardiomyopathy is a major cause of mortality in muscular dystrophy patients.
Neurological and Synaptic Disorders
In the brain, DGC components regulate synaptic function, and their dysfunction has been associated with cognitive deficits, epilepsy, and neuropsychiatric disorders. Dystrophin isoforms in the brain influence synaptic plasticity, and DGC abnormalities may contribute to the neurological symptoms seen in some muscular dystrophies.
Dystroglycanopathies
Defects in glycosylation of alpha-dystroglycan, caused by mutations in genes such as FKRP, POMT1, and POMGNT1, lead to dystroglycanopathies with severe muscle and brain abnormalities. These disorders highlight the importance of extracellular matrix interactions mediated by the DGC.
From dystrophin-associated glycoprotein complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DGC component cause muscle degeneration? | CRISPR knockout of DMD or SGCA in mouse or human myoblasts |
| How do point mutations in DGC genes affect protein interactions? | CRISPR point mutation knock-in in cell lines |
| Can a disease-associated variant be corrected? | CRISPR knock-in of wild-type sequence in patient iPSCs |
| Where and when is a DGC protein expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of utrophin rescue dystrophin loss? | Overexpression of UTRN in DMD models |
| What are the synaptic functions of DGC? | Neuron-specific knockout of DMD or DAG1 in mice |
How to Study the dystrophin-associated glycoprotein complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Protein composition and interactions | DGC interactome mapping |
| Co-immunoprecipitation | Protein-protein interactions | DGC-ion channel interactions |
| Immunofluorescence | Localization and expression | Sarcolemmal and synaptic DGC |
| Electrophysiology | Ion channel function | DGC regulation of excitability |
| CRISPR knockout | Gene function loss | DGC gene essentiality |
| CRISPR knock-in | Variant effects | Disease variant modeling |
| RNA-seq | Transcriptional changes | DGC-related gene expression |
| Proteomics | Protein abundance and modifications | DGC post-translational regulation |
Mass Spectrometry and Proteomics
Mass spectrometry-based proteomics has been used to characterize the DGC interactome, revealing context-dependent composition and post-translational modifications. Affinity purification coupled to mass spectrometry can identify novel DGC-associated proteins and quantify changes in disease models.
Biochemical and Functional Assays
Biochemical assays such as co-immunoprecipitation and pull-downs are used to study interactions between DGC components and ion channels. Functional assays, including electrophysiology and calcium imaging, assess the impact of DGC disruption on cellular physiology.
Imaging and Localization
Immunofluorescence and electron microscopy localize DGC components at the sarcolemma and synapses, and reveal structural abnormalities in disease models. Live-cell imaging with tagged proteins can track DGC dynamics.
Genetic and CRISPR Screens
CRISPR knockout screens can identify modifiers of DGC stability and function, while point mutation and knock-in models dissect specific variants. These approaches are complemented by transcriptomic and proteomic profiling.
How CRISPR Can Be Used to Study GO:0016010 dystrophin-associated glycoprotein complex
Knockout
CRISPR knockout of DGC genes such as DMD, SGCA, or DAG1 in cell and animal models recapitulates key features of muscular dystrophies and allows study of DGC function. Knockout models are used to test therapeutic rescue strategies.
Point Mutation
CRISPR point mutation knock-in introduces specific disease-associated variants into DGC genes, enabling precise analysis of their effects on protein stability, interactions, and function. This approach is valuable for studying missense mutations in sarcoglycans and dystrophin.
Knock-in
Knock-in of tagged DGC proteins (e.g., fluorescent or epitope tags) allows visualization and purification of the complex from cells and tissues. Knock-in of wild-type sequences can correct disease-causing mutations in patient-derived cells.
Overexpression
Overexpression of DGC components or modifiers such as utrophin can compensate for loss of dystrophin and ameliorate disease phenotypes in models. Overexpression studies help identify dose-dependent effects and potential therapeutic targets.
How EDITGENE Supports dystrophin-associated glycoprotein complex Research
Researchers studying dystrophin-associated glycoprotein complex-related genes often need to determine whether a candidate gene is causally involved in DGC assembly, stability, or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for dystrophin-associated glycoprotein complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DAG1 Knockout HeLa Cell Line | EDJ-KQ29 | Human | 1605 | Details Get a Quote |
| UTRN Knockout HEK293 Cell Line | EDJ-KQ1977 | Human | 7402 | Details Get a Quote |
| SGCG Knockout HEK293 Cell Line | EDJ-KQ2755 | Human | 6445 | Details Get a Quote |
| DMD Knockout HEK293 Cell Line | EDJ-KQ3154 | Human | 1756 | Details Get a Quote |
| KRT19 Knockout HEK293 Cell Line | EDJ-KQ3214 | Human | 3880 | Details Get a Quote |
| SGCD Knockout HEK293 Cell Line | EDJ-KQ3448 | Human | 6444 | Details Get a Quote |
| DAG1 Knockout HEK293 Cell Line | EDJ-KQ3800 | Human | 1605 | Details Get a Quote |
| CAV3 Knockout HEK293 Cell Line | EDJ-KQ4196 | Human | 859 | Details Get a Quote |
| DTNB Knockout HEK293 Cell Line | EDJ-KQ4483 | Human | 1838 | Details Get a Quote |
| DTNA Knockout HEK293 Cell Line | EDJ-KQ4484 | Human | 1837 | Details Get a Quote |
| PGM5 Knockout HEK293 Cell Line | EDJ-KQ5451 | Human | 5239 | Details Get a Quote |
| SGCA Knockout HEK293 Cell Line | EDJ-KQ5740 | Human | 6442 | Details Get a Quote |
| SGCB Knockout HEK293 Cell Line | EDJ-KQ5741 | Human | 6443 | Details Get a Quote |
| SNTA1 Knockout HEK293 Cell Line | EDJ-KQ5814 | Human | 6640 | Details Get a Quote |
| SNTB1 Knockout HEK293 Cell Line | EDJ-KQ5815 | Human | 6641 | Details Get a Quote |
Displaying Records 1 To 15 Of 81 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About dystrophin-associated glycoprotein complex
What is the dystrophin-associated glycoprotein complex?
It is a multiprotein complex (GO:0016010) that links the cytoskeleton to the extracellular matrix and includes dystrophin, sarcoglycans, dystroglycan, and other proteins.
What genes are involved in the dystrophin-associated glycoprotein complex?
Key genes include DMD, DAG1, SGCA, SGCB, SGCG, SGCD, SNTA1, SNTB1, DTNA, DTNB, SSPN, CAV3, and NOS1.
What diseases are associated with the dystrophin-associated glycoprotein complex?
Mutations in DGC genes cause muscular dystrophies, cardiomyopathies, and synaptic disorders.
How is the dystrophin-associated glycoprotein complex assembled?
Dystroglycan binds extracellular matrix and dystrophin, which then recruits sarcoglycans, syntrophins, and other components to the membrane.
What is the role of dystrophin in the DGC?
Dystrophin connects the actin cytoskeleton to the DGC, providing mechanical stability to muscle cells.
How can CRISPR be used to study the DGC?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of DGC genes in muscle and neurons.
What methods are used to study the DGC?
Mass spectrometry, co-immunoprecipitation, immunofluorescence, electrophysiology, and CRISPR screens are commonly used.
Is the DGC only found in muscle?
No, it is also present in the nervous system and other tissues, where it has signaling and synaptic roles.
What is the difference between DGC and dystrophin-glycoprotein complex?
They are synonyms; both refer to GO:0016010.
How does DGC dysfunction lead to cardiomyopathy?
Loss of DGC components compromises cardiac sarcolemmal integrity and ion channel regulation, leading to cardiomyopathy.
Conclusion
The dystrophin-associated glycoprotein complex (GO:0016010) is a critical multiprotein complex that maintains mechanical stability and signaling in muscle and nerve. Its dysfunction underlies severe muscular dystrophies, cardiomyopathies, and synaptic disorders, making it a key research focus. Advances in mass spectrometry and CRISPR-based models continue to reveal new insights into DGC composition, regulation, and therapeutic potential.
References
- 1. Waite A et al.. 2009. The neurobiology of the dystrophin-associated glycoprotein complex.. Ann Med 41(5):344-59 PMID: 19172427
- 2. Canessa EH et al.. 2024. Characterization of the dystrophin-associated protein complex by mass spectrometry.. Mass Spectrom Rev 43(1):90-105 PMID: 36420714
- 3. Valera IC et al.. 2021. Essential roles of the dystrophin-glycoprotein complex in different cardiac pathologies.. Adv Med Sci 66(1):52-71 PMID: 33387942
- 4. Pilgram GS et al.. 2010. The roles of the dystrophin-associated glycoprotein complex at the synapse.. Mol Neurobiol 41(1):1-21 PMID: 19899002
- 5. Bozzi M et al.. 2025. Misregulation of the Ubiquitin-Proteasome System and Autophagy in Muscular Dystrophies Associated with the Dystrophin-Glycoprotein Complex.. Cells 14(10) PMID: 40422224
- 6. Leyva-Leyva M et al.. 2018. Biochemical and Functional Interplay Between Ion Channels and the Components of the Dystrophin-Associated Glycoprotein Complex.. J Membr Biol 251(4):535-550 PMID: 29779049
- 7. Bhat HF et al.. 2018. ABC of multifaceted dystrophin glycoprotein complex (DGC).. J Cell Physiol 233(7):5142-5159 PMID: 28464259
- 8. Hopkinson M et al.. 2025. Extracellular matrix: Dystroglycan interactions-Roles for the dystrophin-associated glycoprotein complex in skeletal tissue dynamics.. Int J Exp Pathol 106(2):e12525 PMID: 39923120
